Latest News and Press Releases

Oslo, Norway, 27th of April 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter 2022 Revenue in first quarter ended at MNOK 33 compared...

Oslo, Norway, 20 April 2022 Vistin Pharma ASA will release its first quarter 2022 results on Wednesday 27th of April 2022. Vistin Pharma will host a conference call for all shareholders and...

Oslo, Norway, 17th of February 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2021 Revenue in fourth quarter ended at MNOK 78...

CEO Kjell-Erik Nordby is currently on sick-leave, and the Board in Vistin Pharma, with effect from today, has appointed Magnus Tolleshaug as interim CEO. Magnus Tolleshaug has been employed in Vistin...

Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022. Vistin Pharma will host a conference call for all shareholders and...

Pactum AS, a closely related party to the primary insider and board member Espen W. Marcussen in Vistin Pharma ASA, has on 29 October 2021 sold 3,519,733 shares in Vistin Pharma ASA at NOK 19.50 per...

Oslo, Norway, 28th of October 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2021 Revenue in third quarter ended at MNOK...

Oslo, Norway, 21 October 2021 Vistin Pharma ASA will release its third quarter 2021 results on Thursday 28th of October 2021. Vistin Pharma will host a conference call for all shareholders and...

Tycoon Industrier AS has on 13 September 2021 sold 784,280 shares in Vistin Pharma ASA at NOK 21.1 per share. Ferncliff Listed DAI AS has on 13 September 2021 purchased 784,280 shares in Vistin...

Oslo, Norway, 19th of August 2021 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter 2021 Revenue in second quarter ended at MNOK 66.8...